Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Experts predict that healthcare’s future will increasingly be based on the field of personalized medicine. To move this pharmacogenetics research forward, there is a growing need for biospecimens such as blood, saliva, plasma, and purified DNA. The role of biorepositories and biobanks will be critical here. Yet, biobanks confront significant issues such as material supply, standards development, and sample tracking across multiple organizations.